Higashiyamato, Japan

Hiromi Kaseyama

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Seikagaku Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiromi Kaseyama. Retrieved from https://idiyas.com/inventor/hiromi-kaseyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiromi Kaseyama: Innovator in Chondroitin Production

Introduction

Hiromi Kaseyama is a prominent inventor based in Higashiyamato, Japan. She has made significant contributions to the field of biotechnology, particularly in the production of chondroitin. Her innovative work has led to the development of a unique method for producing this valuable compound.

Latest Patents

Kaseyama holds a patent for a chondroitin-producing bacterium and the method of producing chondroitin. This patent describes a process where chondroitin is produced by culturing a UDP-glucuronic acid-producing bacterium that has been transfected with specific genes derived from the K4 strain. The bacterium exhibits chondroitin-producing ability, and the chondroitin is subsequently collected from it. She has 1 patent to her name.

Career Highlights

Kaseyama is currently employed at Seikagaku Corporation, a company known for its focus on biotechnology and pharmaceuticals. Her work at the company has been instrumental in advancing research and development in the field of chondroitin production.

Collaborations

Throughout her career, Kaseyama has collaborated with notable colleagues, including Kiyoshi Suzuki and Kentaro Miyamoto. These collaborations have further enhanced her research and contributed to the success of her projects.

Conclusion

Hiromi Kaseyama is a trailblazer in the field of chondroitin production, with her innovative methods and collaborative efforts paving the way for advancements in biotechnology. Her contributions are significant and continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…